REPLIMUNE GROUP INC's ticker is REPL and the CUSIP is 76029N106. A total of 112 filers reported holding REPLIMUNE GROUP INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $443,000 | – | 19,230 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 4,673,380 | $81,691,000 | 26.08% |
| Atlas Venture Life Science Advisors, LLC | 3,209,627 | $56,104,000 | 9.38% |
| Redmile Group, LLC | 3,645,309 | $63,720,000 | 2.43% |
| Nan Fung Group Holdings Ltd | 155,199 | $2,713,000 | 1.86% |
| Frazier Life Sciences Management, L.P. | 806,267 | $14,094,000 | 1.33% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 986,270 | $17,240,000 | 1.00% |
| EMERALD ADVISERS, LLC | 1,093,323 | $19,111,000 | 0.98% |
| Artal Group S.A. | 900,000 | $15,732,000 | 0.84% |
| Integral Health Asset Management, LLC | 219,194 | $3,832,000 | 0.79% |
| BVF INC/IL | 926,529 | $16,196,000 | 0.78% |